Share this page!

Enter Twitter Thread URL to Unroll

Needs to be the full URL like: https://twitter.com/threadreaderapp/status/1644127596119195649

How to get URL link on Twitter App

  1. On the Twitter thread, click on or icon on the bottom
  2. Click again on or Share Via icon
  3. Click on Copy Link to Tweet
  4. Paste it above and click "Unroll Thread"!
  5. More info at Twitter Help
Vincent Rajkumar Profile picture
@VincentRK
Jun 4 • 9 tweets • 3 min read Twitter logo Read on Twitter
Scrolly
For #ASCO23

How I treat myeloma: a few slides. Image
Newly diagnosed, not eligible for transplant. Image
First relapse Image
Second or later relapse. @MayoMyeloma mSMART.org Image
Smoldering myeloma Image
Myeloma risk stratification Image
Myeloma active drugs and mechanism of action Image
For those who want more details. @BloodCancerJnl

Still pretty much up to date. nature.com/articles/s4140…
Smoldering myeloma FAQs answered. nature.com/articles/s4140…

• • •

Missing some Tweet in this thread? You can try to force a refresh
　

Keep Current with Vincent Rajkumar

Vincent Rajkumar Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @VincentRK

Vincent Rajkumar Profile picture
Jun 2
mSMART guidelines for management of CAR-T associated cytokine release syndrome, neurotoxicity, cytopenias has just been posted. #myeloma #MedTwitter

@YiLinMDPhD @myelomaMD @MorieGertz @MayoMyeloma

msmart.org
CAR-T associated CRS #ASCO23 Image
CAR-T associated neurotoxicity #ASCO23 Image
Read 6 tweets
Vincent Rajkumar Profile picture
Apr 2
Thanks to the Inflation Reduction Act, 2 big changes coming up for Medicare Part D beneficiaries. #MedTwitter

1) Starting 2024, once you pay ~$3250 out of pocket, you won’t have any more copays. The 5% copay you currently pay will go away. This is HUGE.
#MedTwitter
2) Starting 2025, your annual copay max will be capped at $2000 for Medicare Part D.

Once you spend that much out of pocket, you won’t have any more copays for Part D prescription drugs.
Patients with cancer spend huge amounts in copays currently. The drug Revlimid I prescribe costs $17,000 for 21 day supply.

5% of $17,000 every month is a massive amount of money for most.
Read 5 tweets
Vincent Rajkumar Profile picture
Mar 25
Three concerns I heard from patients at a recent meeting.

#MedTwitter
1/
First, as many complex treatments move from hospital to outpatient setting, patients are being saddled with high bills for parking, food, & lodging.

This is on top of all the usual copays. It widens disparities. Those who can’t afford to pay, don’t get the care they need.
2/
Second, prior authorization is wearing down patients already weary from the illness they have.

Patients have to fight and spend hours with insurance companies to get the tests and treatments their own physicians prescribed for them.

3/
Read 4 tweets
Vincent Rajkumar Profile picture
Mar 17
Breaking: @SanofiUS will cut list price of best selling Lantus insulin by 78%.

Yes! This follows similar announcements by @LillyPad and @novonordiskus
#insulin4all

I hoped this will happen and it has. This will help millions in America. @ZacharyBrennan endpts.com/threes-company…
List price reduction for Lantus starts Jan 2024.

Lillypad announced that it is launching a Lantus equivalent biosimilar at 78% discount to Lantus starting April 1, 2023. And it’s also interchangeable with Lantus.
Sanofi has already a Lantus authorized generic at 70% discount to Lantus launched last year. Let the price drops due to competition begin! It’s good for patients.

Read Sanofi press release: @sanofi sanofi.com/en/media-room/…
Read 7 tweets
Vincent Rajkumar Profile picture
Mar 14
As I had hoped, it has happened. Following @LillyPad decision to cut insulin prices, @novonordiskus follows suit.

Advocacy works. Public pressure works. @Loftus reports. wsj.com/articles/insul…
Insulin manufacturers voluntarily slashing list prices of insulin is monumental— a result of advocacy by patients, advocates like @NSmithholt12 & leaders like @SenSanders

@novonordiskus will cut list price of NovoLog by 75% and Levemir by 65%. Starts January 2024.
Next up, I hope @SanofiUS will follow suit. They make the best seller Lantus.

We also need policy changes at federal level to make this relief enduring and to make sure manufacturers don’t hike prices again. To help all other prescription drugs.
Read 6 tweets
Vincent Rajkumar Profile picture
Mar 11
Pay or Die.
Premieres today @sxsw

@PayorDieFilm
The high cost of Insulin in America. #Insulin4all
@scottaruderman @SarahKSilverman @NSmithholt12
The story behind @PayorDieFilm

payordiefilm.com/directors-stat…
The film is powerful.
Read 6 tweets

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

Send Email!

:(